Home › Funds › Sepio Capital, LP › ABBV

Sepio Capital, LP position in ABBV

ABBVIE INC · Health Care

Sepio Capital, LP reported holding 749,451 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$196.0M, representing 7.83% of its reported portfolio and ranking #2 among its reported holdings. Sepio Capital, LP has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)749.45K sh
Reported value held$196.05M
Portfolio Weight7.83%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Sepio Capital, LP's ABBV position evolved

Sepio Capital, LP first disclosed a stake in ABBV in Q3 2023 at 180,119 shares (US$26.8M). The position peaked in Q3 2026 at 749,451 shares, worth US$196.0M. Across 13 filings, Sepio Capital, LP increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 749,451 shares valued at US$196.0M — an increase of 619,274 shares quarter over quarter.. Notable position changes include a 54% increase in Q3 2024 (shares fell 9% over the following quarter), a 37% increase in Q1 2025 (shares fell 11% over the following quarter), a 476% increase in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 180.12K $26.85M New
Q4 2023 162.79K $25.23M Reduce
Q1 2024 161.25K $29.36M Reduce
Q2 2024 133.25K $22.86M Reduce
Q3 2024 205.46K $40.57M Add
Q4 2024 167.37K $29.74M Reduce
Q1 2025 229.17K $48.01M Add
Q2 2025 209.74K $38.93M Reduce
Q3 2025 134.99K $31.26M Reduce
Q4 2025 125.92K $28.77M Reduce
Q1 2026 136.73K $29.74M Add
Q2 2026 130.18K $32.76M Reduce
Q3 2026 749.45K $196.05M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Sepio Capital, LP held ABBV?

Sepio Capital, LP has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Sepio Capital, LP's current position in ABBV?

As of Q3 2026, Sepio Capital, LP holds 749.45K shares of ABBV (ABBVIE INC), valued at $196.05M, representing 7.83% of its reported portfolio and ranking #2.

Has Sepio Capital, LP been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Sepio Capital, LP increased its position in ABBV. The position peaked in Q3 2026 at 749.45K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.